SMC approves new cancer drugs, among others
admin 14th May 2019 Uncategorised 0Drugs for breast cancer, skin cancer and schizophrenia have been approved. More: SMC approves new cancer drugs, among others Source: News
read moreDrugs for breast cancer, skin cancer and schizophrenia have been approved. More: SMC approves new cancer drugs, among others Source: News
read moreTakeda, in its first year counting the Shire business, has managed to turn up revenue growth. But the upcoming fiscal year could be a different story. More: New Velcade rival, looming Uloric patent loss will cost post-Shire Takeda growth: CEO
read moreA year after Torrent Pharmaceuticals first began recalling tainted losartan products manufactured at its Indrad plant, the FDA paid a visit. It found a plant that often routinely reported products out of specification but frequently shipped them to the U.S.
read moreThe FDA’s final biosimilar interchangeability guidance has language on indication-by-indication data that looks “surprisingly reasonable,” says an analyst. More: FDA's finalized biosim interchangeability rules should give copycats a boost: analyst Source: fierce
read moreIn what could be “the largest cartel case in the history of the United States,” 44 states sued 20 generics makers Friday for price fixing and personally named 15 of those companies’ executives. And at the center of the scheme, the
read moreIt’s been a long road for Eli Lilly’s Cyramza in liver cancer after it belly-flopped a phase 3 trial five years ago. On the back of a successful second attempt, the drugmaker has finally accomplished what once seemed out of
read more© 1994 - 2024 B.M. Pharmaceuticals